The influence of EMMPRIN expression on patient's survival has been reported in glioblastomas, seminomas, and other cancers including tongue, salivary gland, esophageal, ovary, colorectal, breast, bladder, and lung cancers [11–15, 17, 19, 33–36]. Here, BSG is linked to lung carcinoma.